SP17 activators, in this context, encompass a diverse range of compounds that indirectly influence the activity or expression of Sperm Protein 17 (SP17). SP17 is primarily associated with the acrosome reaction in sperm and has been implicated in immunological aspects of cancer research. The compounds listed here do not directly activate SP17 but may impact it through various cellular mechanisms and signaling pathways. The first group, including forskolin, cAMP analogs, and Protein Kinase A inhibitors, operates through the cAMP signaling pathway. Forskolin increases cAMP levels, thereby potentially influencing various cellular processes including those related to SP17. cAMP analogs mimic the role of cAMP and could indirectly modulate SP17 activity. Protein Kinase A, as a key player in the cAMP pathway, might also indirectly influence SP17 when inhibited.
The second group comprises epigenetic and hormonal influencers, including Histone Deacetylase inhibitors, DNA Methyltransferase inhibitors, gonadotropins, retinoic acid, testosterone, and estrogen compounds. These substances can alter gene expression patterns or hormonal balances, potentially affecting SP17 expression in reproductive tissues. For instance, retinoic acid, which is crucial for spermatogenesis, might have an indirect role in modulating SP17 expression. Additionally, epigenetic modifiers that change the chromatin structure can impact the expression of various genes, including possibly SP17. GnRH agonists and antagonists, which regulate the release of gonadotropins, and Bromocriptine, a dopamine agonist influencing pituitary hormone release, can have secondary effects on SP17 levels due to their roles in hormonal regulation. This class of compounds serves as a significant tool for research in reproductive biology, particularly in understanding the regulatory mechanisms of sperm-specific proteins like SP17. While they are not direct activators of SP17, their ability to influence related pathways and processes makes them relevant in studying the regulation and function of SP17 in various biological contexts.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Activates adenylyl cyclase, increasing cAMP levels, which can modulate various cellular processes, potentially affecting SP17. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Involved in cell differentiation and may indirectly influence SP17 expression during spermatogenesis. | ||||||
Bromocriptine | 25614-03-3 | sc-337602A sc-337602B sc-337602 | 10 mg 100 mg 1 g | $57.00 $265.00 $567.00 | 4 | |
As a dopamine agonist that influences pituitary hormone release, it could indirectly affect SP17 expression. | ||||||